These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17058128)

  • 1. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
    ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
    Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
    Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
    Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
    Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
    Moreau LC; Turcotte R; Ferguson P; Wunder J; Clarkson P; Masri B; Isler M; Dion N; Werier J; Ghert M; Deheshi B;
    Ann Surg Oncol; 2012 Apr; 19(4):1081-8. PubMed ID: 22052112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.
    Lin CN; Chou SC; Li CF; Tsai KB; Chen WC; Hsiung CY; Yen CF; Huang HY
    J Surg Oncol; 2006 Mar; 93(4):294-303. PubMed ID: 16496357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
    Gustafson P
    Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases.
    Kilpatrick SE; Doyon J; Choong PF; Sim FH; Nascimento AG
    Cancer; 1996 Apr; 77(8):1450-8. PubMed ID: 8608528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread.
    Schwab JH; Boland P; Guo T; Brennan MF; Singer S; Healey JH; Antonescu CR
    Ann Surg Oncol; 2007 Apr; 14(4):1507-14. PubMed ID: 17252290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
    Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
    Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.
    Schwab JH; Boland PJ; Antonescu C; Bilsky MH; Healey JH
    Cancer; 2007 Oct; 110(8):1815-22. PubMed ID: 17724681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group.
    Svarvar C; Böhling T; Berlin O; Gustafson P; Follerås G; Bjerkehagen B; Domanski HA; Sundby Hall K; Tukiainen E; Blomqvist C;
    Cancer; 2007 Jan; 109(2):282-91. PubMed ID: 17154171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume as a prognostic factor for sarcomatosis.
    Bilimoria MM; Holtz DJ; Mirza NQ; Feig BW; Pisters PW; Patel S; Pollock RE; Benjamin RS; Papadopoulos NE; Plager C; Murphy A; Griffin JR; Burgess MA; Hunt KK
    Cancer; 2002 May; 94(9):2441-6. PubMed ID: 12015769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.